9-40929042-T-C
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000622265.1(MIR1299):n.51A>G variant causes a non coding transcript exon change. The variant allele was found at a frequency of 0.000315 in 3,172 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 109)
Exomes 𝑓: 0.00032 ( 0 hom. )
Consequence
MIR1299
ENST00000622265.1 non_coding_transcript_exon
ENST00000622265.1 non_coding_transcript_exon
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
No conservation score assigned
Publications
0 publications found
Genes affected
MIR1299 (HGNC:35290): (microRNA 1299) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MIR1299 | NR_031629.1 | n.51A>G | non_coding_transcript_exon_variant | Exon 1 of 1 | ||||
| MIR1299 | unassigned_transcript_1614 | n.-11A>G | upstream_gene_variant |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 109
GnomAD3 genomes
Cov.:
109
GnomAD4 exome AF: 0.000315 AC: 1AN: 3172Hom.: 0 Cov.: 0 AF XY: 0.000553 AC XY: 1AN XY: 1808 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
1
AN:
3172
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
1808
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
0
AN:
94
American (AMR)
AF:
AC:
0
AN:
20
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
8
East Asian (EAS)
AF:
AC:
0
AN:
34
South Asian (SAS)
AF:
AC:
0
AN:
120
European-Finnish (FIN)
AF:
AC:
0
AN:
84
Middle Eastern (MID)
AF:
AC:
0
AN:
1630
European-Non Finnish (NFE)
AF:
AC:
1
AN:
898
Other (OTH)
AF:
AC:
0
AN:
284
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.275
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome Cov.: 109
GnomAD4 genome
Cov.:
109
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.